糖尿病多支血管病变血运重建后死亡原因:FREEDOM试验分析
该研究分析FREEDOM试验中1900例糖尿病多支血管病变患者的中心裁定死亡原因,随访5年共197例死亡,63.5%为心血管死亡,猝死最常见。与CABG相比,PCI与缺血相关死亡(猝死及心梗死亡)长期风险增加相关,总体心血管死亡增加无统计学意义。
要点
- 糖尿病多支血管病变血运重建后5年死亡以心血管死亡为主(63.5%),猝死最常见。
- PCI较CABG增加长期缺血相关死亡风险(猝死csHR 2.04,猝死+心梗死亡csHR 2.10)。
- PCI与总体心血管死亡增加无统计学意义(csHR 1.35,P=.09)。
核心结论
- 糖尿病多支血管病变患者血运重建后长期死亡最常见原因为猝死。
- 与CABG相比,PCI与长期缺血相关死亡(猝死及心梗死亡)风险增加相关。
研究设计与样本
- 对FREEDOM试验1900例糖尿病多支血管病变患者进行中心裁定死亡原因分析。
- 采用病因特异性风险比(csHR)比较PCI与CABG的死亡原因。
主要发现
- 5年随访共197例死亡,63.5%为心血管死亡,36.5%为非心血管死亡。
- 猝死占全部心血管死亡的40%,心梗死亡占16%。
- PCI较CABG猝死csHR 2.04(95%CI 1.13-3.70,P=.02)。
- PCI较CABG猝死+心梗死亡复合终点csHR 2.10(95%CI 1.27-3.48,P=.004)。
- PCI较CABG总体心血管死亡csHR 1.35(95%CI 0.95-1.93,P=.09)。
临床怎么用
- 对糖尿病多支血管病变接受PCI者,应加强二级预防以减少血运重建后自发性心肌梗死。
- 手术技术与二级预防应针对降低PCI术后自发性心肌梗死及猝死风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In patients with diabetes and multivessel coronary artery disease, percutaneous coronary intervention (PCI) has been associated with higher long-term cardiovascular mortality compared with coronary artery bypass grafting (CABG), but the specific causes of death are not well known. We aimed to determine the causes of death of patients with diabetes and multivessel disease undergoing coronary revascularization with PCI vs CABG. METHODS: We analyzed the centrally adjudicated causes of death of 1900 participants in the FREEDOM trial. Cause-specific hazard ratios (csHRs) were used to compare mortality rates. RESULTS: There were 197 deaths during the 5 years of follow-up; 63.5% were classified as cardiovascular deaths and the remaining (36.5%), noncardiovascular deaths. Sudden cardiac death was the most common cause of cardiovascular mortality (40% of all cardiovascular deaths), followed by myocardial infarction deaths (16% of all cardiovascular deaths). Compared with CABG, PCI was associated with increased ischemia-related mortality, namely, sudden cardiac death (csHR, 2.04; 95% CI, 1.13-3.70; P = .02) and the composite of sudden cardiac death and myocardial infarction death (csHR, 2.10; 95% CI, 1.27-3.48, P = .004). PCI was associated with a nonsignificant increase in overall cardiovascular mortality compared with CABG (csHR, 1.35; 95% CI, 0.95-1.93; P = .09). CONCLUSIONS: Sudden cardiac death was the most common cause of long-term mortality of patients with diabetes and multivessel coronary artery disease undergoing a revascularization procedure. Compared with CABG, PCI was associated with increased long-term rates of ischemia-related mortality. Operative techniques and secondary prevention should target reducing post-revascularization spontaneous myocardial infarction in patients treated with PCI.
引用
- Godoy LC, Fuster V, Razzouk L, et al. Causes of Death After Coronary Revascularization in Patients With Diabetes. Ann Thorac Surg. 2024. PMID: 39725250. doi:10.1016/j.athoracsur.2024.12.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。